Emerging management and its impact on radioiodine refractory differentiated thyroid cancer / 中国实用外科杂志
Chinese Journal of Practical Surgery
;
(12): 216-220, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-816372
ABSTRACT
Differentiated thyroid cancer(DTC) generally carries good prognosis through standard treatment. While,it could dedifferentiate into radioiodine refractory differentiated thyroid cancer(RAIR-DTC),which progresses rapidly with high mortality and limited treatment methods. Recently,along with the increasing of studies on genetic features,signal transduction pathways and immune microenvironment of RAIR-DTC,as well as the development of new radionuclide tracers,more theoretical bases have been provided for the targeted therapy of RAIR-DTC.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Practical Surgery
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS